KEGG Pathway | Count | % | P-value | Fold Enrichment | Bonferroni |
---|---|---|---|---|---|
Pathways in cancer | 158 | 3.62 | 1.19E-13 | 1.69 | 3.49E-11 |
FoxO signalling pathway | 68 | 1.56 | 2.26E-11 | 2.14 | 6.65E-09 |
Glioma | 40 | 0.92 | 3.67E-10 | 2.59 | 1.08E-07 |
Chronic myeloid leukaemia | 42 | 0.96 | 1.22E-09 | 2.46 | 3.58E-07 |
Prostate cancer | 47 | 1.08 | 5.20E-09 | 2.25 | 1.53E-06 |
Neurotrophin signalling pathway | 56 | 1.28 | 7.08E-08 | 1.97 | 2.08E-05 |
Cell cycle | 57 | 1.30 | 1.01E-07 | 1.94 | 2.97E-05 |
ErbB signalling pathway | 44 | 1.01 | 1.37E-07 | 2.13 | 4.03E-05 |
Hepatitis B | 63 | 1.44 | 2.44E-07 | 1.83 | 7.16E-05 |
p53 signalling pathway | 36 | 0.82 | 3.64E-07 | 2.27 | 1.07E-04 |
PI3K-Akt signalling pathway | 122 | 2.79 | 6.84E-07 | 1.49 | 2.01E-04 |
Viral carcinogenesis | 80 | 1.83 | 1.08E-06 | 1.65 | 3.16E-04 |
Non-small cell lung cancer | 31 | 0.71 | 1.24E-06 | 2.33 | 3.64E-04 |
Bladder cancer | 25 | 0.57 | 1.76E-06 | 2.57 | 5.17E-04 |
Renal cell carcinoma | 34 | 0.78 | 1.82E-06 | 2.21 | 5.35E-04 |
Pancreatic cancer | 34 | 0.78 | 1.82E-06 | 2.21 | 5.35E-04 |
Proteoglycans in cancer | 77 | 1.76 | 3.21E-06 | 1.62 | 9.43E-04 |
TGF-beta signalling pathway | 40 | 0.92 | 3.82E-06 | 2.01 | 0.001123 |
MAPK signalling pathway | 93 | 2.13 | 4.08E-06 | 1.54 | 0.001198 |
Signalling pathways regulating pluripotency of stem cells | 58 | 1.33 | 4.85E-06 | 1.75 | 0.001425 |
Fc epsilon RI signalling pathway | 34 | 0.78 | 6.49E-06 | 2.11 | 0.001905 |
Small cell lung cancer | 39 | 0.89 | 1.52E-05 | 1.93 | 0.004457 |
Ras signalling pathway | 82 | 1.88 | 2.03E-05 | 1.53 | 0.00595 |
Melanoma | 34 | 0.78 | 2.05E-05 | 2.02 | 0.005999 |
T cell receptor signalling pathway | 44 | 1.01 | 3.41E-05 | 1.80 | 0.009978 |
Endocytosis | 90 | 2.06 | 4.31E-05 | 1.47 | 0.01259 |
Epstein-Barr virus infection | 70 | 1.60 | 5.12E-05 | 1.55 | 0.014945 |
Hippo signalling pathway | 58 | 1.33 | 6.68E-05 | 1.62 | 0.019459 |
Insulin signalling pathway | 54 | 1.24 | 7.01E-05 | 1.65 | 0.020398 |
Thyroid hormone signalling pathway | 46 | 1.05 | 1.15E-04 | 1.70 | 0.033145 |
Oestrogen signalling pathway | 41 | 0.94 | 1.50E-04 | 1.75 | 0.043177 |
Acute myeloid leukaemia | 27 | 0.62 | 1.56E-04 | 2.03 | 0.044742 |
Rap1 signalling pathway | 74 | 1.69 | 1.58E-04 | 1.49 | 0.045381 |
Colorectal cancer | 29 | 0.66 | 1.59E-04 | 1.97 | 0.045785 |